Atlas Trials

Study to Assess the Pharmacokinetics and Safety of AZD9977 in Participants With Renal Impairment

Clinical trial NCT04469907 · COMPLETED

Trial details

NCT number
NCT04469907
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Renal Impairment
Start date
2020-06-22
Primary completion
2021-10-28
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.